
Syngene acquires first US facility from Emergent Manufacturing
Syngene International, the contract research wing of Biocon Group, has acquired its first manufacturing facility in the US from Emergent Manufacturing Operations Baltimore. The pharma player has invested around $50 million, including the cost of …